ClinicalTrials.Veeva

Menu

Accessible and Inclusive Diabetes Telecoaching Self-Management Program

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Completed

Conditions

Disability Physical
Diabete Type 2

Treatments

Behavioral: Attention-control
Behavioral: AI4DM

Study type

Interventional

Funder types

Other

Identifiers

NCT04927377
IRB-300007168

Details and patient eligibility

About

The purpose of this study is to develop and pilot test an accessible and inclusive Artificial Intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4DM) for glycemic control in people with disabilities.

Full description

The AI4DM study will use a two-arm randomized control trial design. Eligible and consented participants will be assigned to one of two groups: 1) AI4DM intervention group with telecoaching support, and 2) attention-control group. The active intervention period will include six months of weekly and bi-weekly telecoaching calls followed by six months of follow-up and technology access, but no telecoaching calls.

Enrollment

90 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Type 2 Diabetes Mellitus,
  • Living with a permanent physical disability such as spinal cord injury (SCI), spina bifida, multiple sclerosis, stroke, etc.
  • Ability to converse and read in English

Exclusion criteria

  • Current enrollment in any diabetes-related intervention
  • Severe untreated depression in the past six months
  • Major cardiac event in the past twelve months
  • Uncontrolled blood pressure
  • Resting tachycardia
  • Renal failure
  • Severe peripheral neuropathy
  • Unavailability of a smartphone

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 2 patient groups

AI4DM Intervention Group
Experimental group
Treatment:
Behavioral: AI4DM
Attention-control Group
Active Comparator group
Treatment:
Behavioral: Attention-control

Trial contacts and locations

1

Loading...

Central trial contact

Mohanraj Thirumalai, PhD; Eric J Evans, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems